Haemonetics
HAE
$84.08
Share price
-0.67%
Change (1 day)
-0.61%
Change (1 year)
Categories
Haemonetics (HAE) - Total debt
Total debt on the balance sheet as of March 2024 : $0.80 B
According to Haemonetics's latest financial reports the company's total debt is $0.80 B. A company’s total debt is the sum of all current and non-current debts.
Haemonetics - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-03-31 | $0.76 B | -1% |
| 2022-03-31 | $0.77 B | 8.15% |
| 2021-03-31 | $0.71 B | 61.9% |
| 2020-03-31 | $0.44 B | 26.19% |
| 2019-03-31 | $0.35 B | 38.02% |
| 2018-03-31 | $0.25 B | -19.38% |
| 2017-03-31 | $0.31 B | -22.88% |
| 2016-03-31 | $0.40 B | -4.65% |
| 2015-03-31 | $0.42 B | -2.24% |
| 2014-03-31 | $0.43 B | -8.83% |
| 2013-03-31 | $0.48 B | 12631.21% |
| 2012-03-31 | $3.77 M | -22.71% |
| 2011-03-31 | $4.87 M | -76.22% |
| 2010-03-31 | $20.52 M | 239.85% |
| 2009-03-31 | $6.03 M | -51.16% |
| 2008-03-31 | $12.36 M | -57.19% |
| 2007-03-31 | $28.87 M | -26.25% |
| 2006-03-31 | $39.15 M | -14.59% |
| 2005-03-31 | $45.84 M | -21.31% |
| 2004-03-31 | $58.26 M | -17.5% |
| 2003-03-31 | $70.61 M | -2.12% |
| 2002-03-31 | $72.14 M | 3.48% |
| 2001-03-31 | $69.71 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $33.63 B | 4,063.44% | 🇺🇸 USA |
 Medtronic MDT | $25.18 B | 3,017.38% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $35.60 B | 4,308.06% | 🇺🇸 USA |
 Baxter BAX | $14.17 B | 1,654.16% | 🇺🇸 USA |
 Becton Dickinson BDX | $18.01 B | 2,129.66% | 🇺🇸 USA |
 Stryker Corporation SYK | $12.86 B | 1,492.61% | 🇺🇸 USA |
 PerkinElmer
PKI | $4.50 B | 458.29% | 🇺🇸 USA |
 Cerus CERS | $0.10 B | -87.55% | 🇺🇸 USA |